Secondary
Autoimmune Thrombocytopenias
Thrombocytopenias
that are a result of:
Interferon therapy
Colony-Stimulating factor therapy
Interleukin-2 therapy
CLL – 5-10% will develop
thrombocytopenia
SLE – 14-26% will develop
thrombocytopenia